FASN and lung carcinoma: During the A549 lung cancer cell culture in the microwells, the introduction of GSK2194069, a selective fatty acid synthase inhibitor, promoted the intracellular accumulation of fatty acid synthase (FASN), allowing MALDI–MS to determine the influence of concentration on the inhibition process through ion intensity imaging of a superwettable array.